175 related articles for article (PubMed ID: 15752909)
1. Inverse treatment planning based on MRI for HDR prostate brachytherapy.
Citrin D; Ning H; Guion P; Li G; Susil RC; Miller RW; Lessard E; Pouliot J; Huchen X; Capala J; Coleman CN; Camphausen K; Ménard C
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1267-75. PubMed ID: 15752909
[TBL] [Abstract][Full Text] [Related]
2. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
[TBL] [Abstract][Full Text] [Related]
3. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.
Pouliot J; Kim Y; Lessard E; Hsu IC; Vigneron DB; Kurhanewicz J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1196-207. PubMed ID: 15234056
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
[TBL] [Abstract][Full Text] [Related]
5. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
9. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
Morton GC; Sankreacha R; Halina P; Loblaw A
Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
[TBL] [Abstract][Full Text] [Related]
10. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
12. MRI-based preplanning in low-dose-rate prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
Hsu IC; Lessard E; Weinberg V; Pouliot J
Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
[TBL] [Abstract][Full Text] [Related]
14. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
15. MRI/TRUS data fusion for brachytherapy.
Daanen V; Gastaldo J; Giraud JY; Fourneret P; Descotes JL; Bolla M; Collomb D; Troccaz J
Int J Med Robot; 2006 Sep; 2(3):256-61. PubMed ID: 17520640
[TBL] [Abstract][Full Text] [Related]
16. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning.
Krempien RC; Daeuber S; Hensley FW; Wannenmacher M; Harms W
Brachytherapy; 2003; 2(3):164-71. PubMed ID: 15062139
[TBL] [Abstract][Full Text] [Related]
17. Anatomy based inverse planning in HDR prostate brachytherapy.
Kolkman-Deurloo IK; Deleye XG; Jansen PP; Koper PC
Radiother Oncol; 2004 Oct; 73(1):73-7. PubMed ID: 15465149
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods.
van den Bosch MR; Lips IM; Lagerburg V; van Vulpen M; Lagendijk JJ; Moerland MA
Radiother Oncol; 2008 Jan; 86(1):120-5. PubMed ID: 18037520
[TBL] [Abstract][Full Text] [Related]
19. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
20. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.
Dewitt KD; Hsu IC; Speight J; Weinberg VK; Lessard E; Pouliot J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1270-4. PubMed ID: 16253782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
